The main focus in Teva’s innovative portfolio continues to be neuroscience and immunology, with clinical trials for three key assets underway: olanzapine for treatment of schizophrenia, ...

“Our technology is purpose-built ... In the first ever case filed in a PBM administrative court, the state of Oklahoma is suing CVS Caremark, alleging the insurer reimbursed below acquisition ...

Congress nearly passed legislation to restrict pharmacy benefit manager business practices at the end of 2024.

The FTC called out the nation’s leading pharmacy benefit managers for inflating pharmacy costs, affecting both employers and ...

CVS's app is designed as a one-stop shop for customers to do everything from manage prescriptions to opening locked display ...

Pharmacy benefit managers overcharged for specialty generic medications — in many cases by hundreds and thousands of percent ...

Last year, the Federal Trade Commission (FTC) caused consternation among pharmacy benefit managers (PBMs ... the big three players in the sector – CVS' Caremark, Cigna's Express Scripts ...

Journey Medical's future hinges on Emrosi, a new formulation of minocycline for rosacea, showing superior efficacy. Read why ...

CVS' diverse operations create the opportunity to view a patient more holistically by managing both medical and pharmacy benefits, which could lead to revenue and cost synergies for the ...